US2009081785A1PendingUtilityA1
Desiccated Biologics And Methods Of Preparing The Same
Assignee: HEMEMICS BIOTECHNOLOGIES INCPriority: Sep 24, 2007Filed: Sep 22, 2008Published: Mar 26, 2009
Est. expirySep 24, 2027(~1.2 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 7/00A61P 7/04A61P 1/18A61K 35/19A61K 35/44A61K 35/545A61P 1/16A61K 35/14A61K 9/19A61K 45/06A61K 47/26A61P 21/00A61K 9/0019A61K 35/18A61P 15/08A61K 35/76A61P 13/12A61P 19/00A01N 1/128A01N 1/122A01N 1/10A01N 1/126A61K 35/17
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides compositions comprising desiccated biologics comprising a cell, protein, virus, nucleic acid, carbohydrate, or lipid, or any combination thereof, along with at least one membrane penetrable sugar, and at least one membrane impenetrable sugar, wherein the moisture content is from 5% to 95%, and to methods of preparing the same, and to methods of treating animals using the same.
Claims
exact text as granted — not AI-modified1 . A composition comprising:
one or more biologics; one or more membrane penetrable sugars; and one or more membrane impenetrable sugars; wherein the moisture content of the composition is from about 5% to about 95%.
2 . The composition of claim 1 wherein the biologic is a cell.
3 . The composition of claim 2 wherein the cell is anucleated.
4 . The composition of claim 3 wherein the anucleated cell is a platelet or red blood cell.
5 . The composition of claim 2 wherein the cell is nucleated.
6 . The composition of claim 5 wherein the nucleated cell is a white blood cell, a stem cell, a stem cell progenitor cell, a gamete, a gamete progenitor cell, a hepatocyte, a muscle cell, a kidney cell, an endothelial cell, an epithelial cell, an erythroblast, a leukoblast, a chondroblast, or a pancreatic cell.
7 . The composition of claim 1 wherein the biologic is a protein, virus, nucleic acid, carbohydrate, or lipid.
8 . The composition of claim 1 wherein the membrane penetrable sugar is trehalose.
9 . The composition of claim 1 wherein the membrane impenetrable sugar is dextran.
10 . The composition of claim 1 wherein the moisture content is from about 15% to about 40%.
11 . The composition of claim 1 wherein the moisture content is from about 20% to about 25%.
12 . The composition of claim 1 wherein the biologic is a platelet, the membrane penetrable sugar is trehalose, the membrane impenetrable sugar is dextran, and the moisture content is about 15%.
13 . The composition of claim 1 wherein the biologic is a red blood cell, the membrane penetrable sugar is trehalose, the membrane impenetrable sugar is dextran, and the moisture content is about 25%.
14 . The composition of claim 1 wherein the biologic is a white blood cell, the membrane penetrable sugar is trehalose, the membrane impenetrable sugar is dextran, and the moisture content is about 50%.
15 . A method of preserving a biologic comprising:
contacting the biologic with at least one membrane penetrable sugar and at least one membrane impenetrable sugar; optionally, contacting the biologic with a fixative agent; and drying the biologic by vacuum desiccation to a final moisture content of from about 5% to about 90%.
16 . The method of claim 15 wherein the biologic is a cell.
17 . The method of claim 16 wherein the cell is anucleated.
18 . The method of claim 17 wherein the anucleated cell is a platelet or red blood cell.
19 . The method of claim 16 wherein the cell is nucleated.
20 . The method of claim 19 wherein the nucleated cell is a white blood cell, a stem cell, a stem cell progenitor cell, a gamete, a gamete progenitor cell, a hepatocyte, a muscle cell, a kidney cell, an endothelial cell, an epithelial cell, an erythroblast, a leukoblast, a chondroblast, or a pancreatic cell.
21 . The method of claim 15 wherein the biologic is a protein, virus, nucleic acid, carbohydrate, or lipid.
22 . The method of claim 15 wherein the membrane penetrable sugar is trehalose.
23 . The method of claim 15 wherein the membrane impenetrable sugar is dextran.
24 . The method of claim 15 wherein the moisture content is from about 15% to about 40%.
25 . The method of claim 15 wherein the moisture content is from about 20% to about 25%.
26 . The method of claim 15 wherein the fixative agent is glutaraldehyde or paraformaldehyde.
27 . The method of claim 15 wherein the biologic is dried by vacuum desiccation at temperatures ranging from about 0° C. to about 40° C. for about 1 hours to about 4 hours.
28 . The method of claim 27 wherein the biologic is dried by vacuum desiccation at temperatures ranging from about 32° C. to about 34° C. for about 3 hours.
29 . The method of claim 15 further comprising storing the biologic in a vacuum sealed container in the presence or absence of a desiccant.
30 . The method of claim 15 further comprising rehydrating the biologic.
31 . The method of claim 30 wherein the rehydration comprises contacting the biologic with water, optionally followed by saline.
32 . The method of claim 15 wherein the biologic is a platelet, the membrane penetrable sugar is trehalose, the membrane impenetrable sugar is dextran, and the moisture content is about 15%.
33 . The method of claim 15 wherein the biologic is a red blood cell, the membrane penetrable sugar is trehalose, the membrane impenetrable sugar is dextran, and the moisture content is about 25%.
34 . The method of claim 15 wherein the biologic is a white blood cell, the membrane penetrable sugar is trehalose, the membrane impenetrable sugar is dextran, and the moisture content is about 50%.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.